Theranos Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Out of Business

  • Employees
  • 416

Employees

  • Latest Deal Type
  • Liquidation

Theranos General Information

Description

Developer of bio-monitoring systems designed to facilitate small-sample collections, testing, and rapid communication of diagnostic information. The company's system creates an integrated infrastructure for real-time testing, decision-making, and individualized therapy, enabling laboratories to process early detection and intervention.

Contact Information

Website
www.theranos.com
Formerly Known As
RealTime Cures
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1701 Page Mill Road
  • Palo Alto, CA 94304
  • United States
Primary Industry
Medical Supplies
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 1701 Page Mill Road
  • Palo Alto, CA 94304
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Theranos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Bankruptcy: Liquidation 05-Sep-2018 Completed Bankruptcy: Liquidation
10. Debt - General 23-Dec-2017 Completed Generating Revenue
9. Secondary Transaction - Private 27-Mar-2017 Completed Generating Revenue
8. Later Stage VC (Series C3) 01-Oct-2015 Cancelled Generating Revenue
7. Later Stage VC Completed Generating Revenue
6. Later Stage VC (Series C2) 04-Feb-2014 Completed Generating Revenue
5. Later Stage VC 28-Mar-2013 Completed Generating Revenue
4. Later Stage VC 08-Jul-2010 Completed Generating Revenue
3. Later Stage VC (Series C) 15-Nov-2006 $32.4M $48.4M Completed Startup
2. Early Stage VC (Series B) 16-Feb-2006 $9.1M $16M Completed Startup
To view Theranos’s complete valuation and funding history, request access »

Theranos Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C3
Series C2
Series C1
Series C
Series B 54,162,965 $0.000100 $0.18 $0.18 1x $0.18 10.03%
Series A 46,320,045 $0.000100 $0.15 $0.15 1x $0.15 8.58%
To view Theranos’s complete cap table history, request access »

Theranos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of bio-monitoring systems designed to facilitate small-sample collections, testing, and rapid communication of
Medical Supplies
Palo Alto, CA
416 As of 2023

Fremont, CA
 

Union City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Theranos Competitors (4)

One of Theranos’s 4 competitors is ARK Diagnostics, a Formerly VC-backed company based in Fremont, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ARK Diagnostics Formerly VC-backed Fremont, CA
Abaxis Formerly VC-backed Union City, CA
Quest Diagnostics Corporation Secaucus, NJ
Everly Health Venture Capital-Backed Austin, TX
To view Theranos’s complete competitors history, request access »

Theranos Patents

  • 152

    Total Documents Applications and Grants

  • Total Patents Families

  • 61

    Granted

  • 20

    Pending

  • Expiring in next 12 mo

Theranos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2994826-A1 Transfer vessel and methods for reducing sample loss Inactive 04-Aug-2015
JP-2018528411-A Systems, devices, and methods for collecting, transporting and handling bodily fluid samples Inactive 21-Jul-2015
CA-2993316-A1 Systems, devices, and methods for bodily fluid sample collection, transport, and handling Inactive 21-Jul-2015
JP-2017531424-A Hybrid multi-step nucleic acid amplification Inactive 17-Sep-2014
JP-2017532030-A Diagnostic method and composition Inactive 17-Sep-2014 C12Q1/707
To view Theranos’s complete patent history, request access »

Theranos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Theranos FAQs

  • When was Theranos founded?

    Theranos was founded in 2003.

  • Where is Theranos headquartered?

    Theranos is headquartered in Palo Alto, CA.

  • What is the size of Theranos?

    Theranos has 416 total employees.

  • What industry is Theranos in?

    Theranos’s primary industry is Medical Supplies.

  • Is Theranos a private or public company?

    Theranos is a Private company.

  • What is Theranos’s current revenue?

    The current revenue for Theranos is .

  • How much funding has Theranos raised over time?

    Theranos has raised $1.05B.

  • Who are Theranos’s competitors?

    ARK Diagnostics, Abaxis, Quest Diagnostics, and Everly Health are competitors of Theranos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »